Aspire Biopharma (ASBP) Competitors $0.28 +0.04 (+17.95%) As of 11:16 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsTrendsBuy This Stock ASBP vs. MNOV, VHAQ, QNCX, ANRO, CLSD, CRVO, ACHL, RPTX, VTGN, and SNTIShould you be buying Aspire Biopharma stock or one of its competitors? The main competitors of Aspire Biopharma include MediciNova (MNOV), Viveon Health Acquisition (VHAQ), Quince Therapeutics (QNCX), Alto Neuroscience (ANRO), Clearside Biomedical (CLSD), CervoMed (CRVO), Achilles Therapeutics (ACHL), Repare Therapeutics (RPTX), VistaGen Therapeutics (VTGN), and Senti Biosciences (SNTI). These companies are all part of the "pharmaceutical products" industry. Aspire Biopharma vs. Its Competitors MediciNova Viveon Health Acquisition Quince Therapeutics Alto Neuroscience Clearside Biomedical CervoMed Achilles Therapeutics Repare Therapeutics VistaGen Therapeutics Senti Biosciences Aspire Biopharma (NASDAQ:ASBP) and MediciNova (NASDAQ:MNOV) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, dividends, risk, media sentiment, valuation, earnings, profitability and institutional ownership. Which has more risk and volatility, ASBP or MNOV? Aspire Biopharma has a beta of 0.91, indicating that its share price is 9% less volatile than the S&P 500. Comparatively, MediciNova has a beta of 0.42, indicating that its share price is 58% less volatile than the S&P 500. Do insiders & institutionals have more ownership in ASBP or MNOV? 19.2% of Aspire Biopharma shares are held by institutional investors. Comparatively, 9.9% of MediciNova shares are held by institutional investors. 48.0% of Aspire Biopharma shares are held by insiders. Comparatively, 13.6% of MediciNova shares are held by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term. Does the media prefer ASBP or MNOV? In the previous week, Aspire Biopharma had 1 more articles in the media than MediciNova. MarketBeat recorded 3 mentions for Aspire Biopharma and 2 mentions for MediciNova. MediciNova's average media sentiment score of 1.02 beat Aspire Biopharma's score of 0.38 indicating that MediciNova is being referred to more favorably in the news media. Company Overall Sentiment Aspire Biopharma Neutral MediciNova Positive Is ASBP or MNOV more profitable? Aspire Biopharma's return on equity of 0.00% beat MediciNova's return on equity.Company Net Margins Return on Equity Return on Assets Aspire BiopharmaN/A N/A -508.70% MediciNova N/A -20.77%-19.68% Do analysts recommend ASBP or MNOV? MediciNova has a consensus price target of $7.00, indicating a potential upside of 434.35%. Given MediciNova's stronger consensus rating and higher probable upside, analysts plainly believe MediciNova is more favorable than Aspire Biopharma.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Aspire Biopharma 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00MediciNova 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 1 Strong Buy rating(s) 3.50 Which has higher earnings and valuation, ASBP or MNOV? MediciNova has higher revenue and earnings than Aspire Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAspire BiopharmaN/AN/A-$12.54MN/AN/AMediciNova$1M64.25-$11.04M-$0.23-5.70 SummaryMediciNova beats Aspire Biopharma on 8 of the 13 factors compared between the two stocks. Get Aspire Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for ASBP and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding ASBP and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ASBP vs. The Competition Export to ExcelMetricAspire BiopharmaMED IndustryMedical SectorNASDAQ ExchangeMarket Cap$14.00M$2.83B$5.43B$8.79BDividend YieldN/A2.69%5.37%4.21%P/E RatioN/A20.9125.7619.50Price / SalesN/A234.47376.0798.78Price / CashN/A43.0735.9456.46Price / Book-0.137.317.925.52Net Income-$12.54M-$55.10M$3.14B$248.18M7 Day Performance-11.10%1.19%1.16%1.95%1 Month PerformanceN/A8.14%5.41%5.63%1 Year PerformanceN/A0.74%39.04%18.09% Aspire Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ASBPAspire BiopharmaN/A$0.28+17.9%N/AN/A$14.00MN/A0.00N/AGap UpHigh Trading VolumeMNOVMediciNova2.4911 of 5 stars$1.29+1.6%$7.00+442.6%-5.6%$62.29M$1M-5.6110Positive NewsVHAQViveon Health AcquisitionN/A$11.00flatN/AN/A$62.26MN/A0.002High Trading VolumeQNCXQuince Therapeutics3.6269 of 5 stars$1.30-4.4%$8.00+515.4%+132.7%$61.84MN/A-0.9460News CoverageANROAlto Neuroscience1.5811 of 5 stars$2.22-2.2%$8.50+282.9%-73.8%$61.45MN/A-0.95N/ANews CoverageGap DownCLSDClearside Biomedical2.7244 of 5 stars$0.84+6.3%$4.80+471.6%-32.8%$61.39M$1.66M-2.0530Positive NewsGap DownHigh Trading VolumeCRVOCervoMed3.3045 of 5 stars$6.85-2.0%$27.63+303.3%-65.9%$60.83M$9.74M-3.144ACHLAchilles TherapeuticsN/A$1.48flatN/AN/A$60.83MN/A-0.90250RPTXRepare Therapeutics2.6933 of 5 stars$1.41flat$4.50+219.1%-59.8%$60.48M$53.48M-0.47180News CoveragePositive NewsVTGNVistaGen Therapeutics1.0741 of 5 stars$2.00-2.9%N/A-38.9%$60.06M$490K-1.2040Analyst RevisionHigh Trading VolumeSNTISenti Biosciences2.9084 of 5 stars$2.13-6.6%$8.50+299.1%-27.3%$59.47M$2.56M-0.204Gap Up Related Companies and Tools Related Companies MNOV Alternatives VHAQ Alternatives QNCX Alternatives ANRO Alternatives CLSD Alternatives CRVO Alternatives ACHL Alternatives RPTX Alternatives VTGN Alternatives SNTI Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ASBP) was last updated on 6/26/2025 by MarketBeat.com Staff From Our PartnersIs Elon's empire crumbling?The Tesla Shock Nobody Sees Coming While headlines scream "Tesla is doomed"... Jeff Brown has uncovered ...Brownstone Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump set to Boost Social Security Checks by 400%?If you're currently collecting—or planning to collect—Social Security benefits, there's an urgent development ...InvestorPlace | SponsoredWar Tensions Are Making Gold Rise to Record HighsIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredTrump’s true trade war strategyThe media and financial pundits are all misreading Trump’s actions. They think Trump wants to make Canada t...Porter & Company | SponsoredThe $7 company helping Nvidia build the world’s first trillion-dollar robot …Michael Robinson has been at the forefront of the technology market for over 40 years. Spotting some profit...Weiss Ratings | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aspire Biopharma Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aspire Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy ASBP Stock Free ASBP Stock Alerts